Not Yet RecruitingNot Applicable

Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

United States40 participantsStarted 2026-06-22

Plain-language summary

The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in men with androgenic alopecia. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 visits after voluntary consent has been given. Participants will be given a 90-day supply of the gummies at visits 1 and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

Who can participate

Age range

18 Years – 65 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males aged 18-65 * Norwood III to IV, vertex focused * Fitzpatrick skin type I to VI * Ability and willingness to comply with study protocol Exclusion Criteria: * Change in other hair treatments in 3 months prior to study enrollment. * Known uncontrolled health conditions. * History of hair or scalp disorders that could interfere with study results. * History of metabolic syndrome.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram Analysis

Timeframe: From enrollment to the end of treatment at 6 months

Within-subject increase in hair thickness assessed via Canfield HairMetrix® Phototrichogram Analysis

Timeframe: From enrollment to the end of treatment at 6 months

Hair Density Changes measured by SOCAi

Timeframe: From enrollment to the end of treatment at 6 months

Trial details

NCT IDNCT07637071

SponsorRestore Biologics Holdings, Inc. dba Xtressé

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-01

Contact for this trial

Dr. Matt Leavitt, DO

321-594-6851 matt@xtresse.com

View on ClinicalTrials.gov More Androgenic Alopecia trials

Plain-language summary

Who can participate

Age range

18 Years – 65 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram Analysis

Timeframe: From enrollment to the end of treatment at 6 months

Within-subject increase in hair thickness assessed via Canfield HairMetrix® Phototrichogram Analysis

Timeframe: From enrollment to the end of treatment at 6 months

Hair Density Changes measured by SOCAi

Timeframe: From enrollment to the end of treatment at 6 months